Cancer study identifies likely responders to immune therapy
The newest cancer therapies don’t work on everyone. Now, doctors have a clue why When neoantigens are found throughout a tumor, patients have the best shot at benefitting from immunotherapy drugs like Keytruda and Yervoy.
No comments:
Post a Comment